Sophisticated computer models, or virtual patients, that can simulate how a device will function in a patient, could eventually cut the cost and time of device clinical trials, but manufacturers will have to cooperate with each other and regulatory agencies to reach that goal, according to Medtronic statistician Tarek Haddad.
"Even at a big company like Medtronic, we still don't have the resources to do everything so if we really...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?